Clearance

Clearance represents a pharmacokinetic parameter describing the volume of plasma or blood from which a drug is completely removed per unit time through processes such as metabolism and excretion. It reflects the body's ability to eliminate a drug and is a key determinant of dosing regimens, exposure levels, and potential accumulation. Clearance can occur through hepatic metabolism, renal elimination, or other pathways, and may vary based on patient factors including organ function, genetics, age, and drug-drug interactions.

The pharmaceutical industry relies on clearance measurements to design safe and effective dosing strategies across development programmes. Clinical pharmacology studies assess clearance in healthy volunteers and patient populations, including special groups such as those with renal impairment or hepatic dysfunction. Biologics often exhibit distinct clearance mechanisms compared to small molecules, including target-mediated drug disposition, Fc receptor recycling, and immunogenicity-related clearance changes. Clearance data supports exposure-response modelling, dose selection, and labelling recommendations for dose adjustments. Regulatory submissions require robust clearance characterisation to ensure appropriate dosing across populations and to support safe product use in clinical practice.